About 98.9 lakh shares or 7.27 percent equity changed hands in an early trade block deal on Thursday, August 22 at Rs 1201 per share at Rs 1187 crore.
Moneycontrol could not ascertain buyers or sellers in the block deal window immediately.
The counter of the pharma stock was trading at Rs 1,247.45 per share on the National Stock Exchange (NSE), rising nearly 3 percent. The stock has been gaining for the last three days and has risen 3.75 percent in the period.
The counter had opened with a gain of 2.24 percent today, touching an intraday high of Rs 1250 apiece, up 3.07 percent.
Earlier in July, Franklin Templeton raised its stake in Eris Lifesciences by acquiring an additional 0.8 percent equity, valued at Rs 109 crore. This brings Franklin Templeton's total stake to 2.26 percent, up from 1.46 percent.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
